This site uses cookies to help us manage and improve the website and to analyse how visitors use our site. By continuing to use the website, you are agreeing to our use of cookies. For further information about cookies, including about how to change your browser settings to no longer accept cookies, please view our Cookie Policy. Click for more info.

Healthcare M&A activity remains robust

Healthcare M&A activity remains robust despite a backdrop of political and economic uncertainty and the demand for quality healthcare assets is set to continue. There were a number of significant healthcare transactions in 2018, including Core Equity's investment in Portman Dental and iCON's investment in Choice Care. Similarly, 2019 is already off to a strong start with August investing in veterinary diagnostic business, Hallmarq Veterinary, Waterland's investment in residential childcare operator, Sandcastle Care, and Swedish investor Impilo acquiring a majority stake in The Fertility Partnership. Additionally, there are several high-profile processes already in advanced stages across a range of sub-sectors including fertility, social care and elderly care.

Further analysis reveals there have been 77 transactions in the global IVF and fertility treatment market since 2009. The research which analyses deals in the sector across 12 different countries also shows that M&A activity was at its highest level in 2018, 22 transactions were completed last year alone accounting for almost 30% of the total across the last 10 years.

The positive momentum in the UK healthcare sector shows no sign of abating and strong underlying market growth continues to be a driver of M&A volumes and valuations. The appetite from international and domestic corporates will continue to grow and PE investors, who are raising ever increasing funds, will continue to actively seek assets of quality and scale as pressure to deploy closed-end funds increases.

In this edition of our Healthcare Newsletter, we:

  •   Analyse investment into the mental health sector;
  •   Examine current valuation trends in the fertility market;
  •   Provide in-depth insight into the deals that made the headlines in the last 18 months;
  •   Discuss what creates value for sellers in the healthcare sector;
  •   Explore the emerging trends in the pharmaceutical sector; and
  •   Consider the M&&A outlook for the remainder of 2019.

To request your full copy of our Healthcare Newsletter, please email Rosemarie Lamanno rosemarie.lamanno@arrowpointadvisory.com

Karen Dawaf Harron

Karen Dawaf Harron

Director

Phone: +44 20 7484 4730

Mobile: +44 7901 666735

Dustin Stevens

Dustin Stevens

Associate

Phone: +44 20 7484 4702

Mobile: +44 7551 650375

Healthcare